Articles

• Education, cognitive function, and severity of neuropathology in Alzheimer disease

  T. D. Koepsell, B. F. Kurland, O. Harel, E. A. Johnson, X. -H. Zhou, W. A. Kukull

  • Abstract
  • Full Text
  • Full Text (PDF)
• Atrophy rates accelerate in amnestic mild cognitive impairment

  C. R. Jack, S. D. Weigand, M. M. Shiung, S. A. Przybelski, P. C. O’Brien, J. L. Gunter, D. S. Knopman, B. F. Boeve, G. E. Smith, R. C. Petersen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity

  W. Li, T. M. Malpica-Llanos, R. Gundry, R. J. Cotter, N. Sacktor, J. McArthur, A. Nath

  • Abstract
  • Full Text
  • Full Text (PDF)
• Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia

  J. M. Olichney, J. R. Taylor, J. Gatherwright, D. P. Salmon, A. J. Bressler, M. Kutas, V. J. Iragui-Madoz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Apolipoprotein E genotype and memory in the sixth decade of life

  M. R. Schultz, M. J. Lyons, C. E. Franz, M. D. Grant, C. Boake, K. C. Jacobson, H. Xian, G. D. Schellenberg, S. A. Eisen, W. S. Kremen

  • Abstract
  • Full Text
  • Full Text (PDF)
• Occurrence of cognitive impairment and dementia in the communityA 9-year-long prospective study

  B. Caracciolo, K. Palmer, R. Monastero, B. Winblad, L. Bäckman, L. Fratiglioni

  • Abstract
  • Full Text
  • Full Text (PDF)
• Physical activity and dementia risk in the elderlyFindings from a prospective Italian study

  G. Ravaglia, P. Forti, A. Lucicesare, N. Pisacane, E. Rietti, M. Bianchin, E. Dalmonte

  • Abstract
  • Full Text
  • Full Text (PDF)
• Statins, incident Alzheimer disease, change in cognitive function, and neuropathology

  Z. Arvanitakis, J. A. Schneider, R. S. Wilson, J. L. Bienias, J. F. Kelly, D. A. Evans, D. A. Bennett

  • Abstract
  • Full Text
  • Full Text (PDF)
• Associations of job demands and intelligence with cognitive performance among men in late life

  Guy G. Potter, Michael J. Helms, Brenda L. Plassman

  • Abstract
  • Full Text
  • Full Text (PDF)
• A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline

  H. H. Dodge, T. Zitzelberger, B. S. Oken, D. Howieson, J. Kaye

  • Abstract
  • Full Text
  • Full Text (PDF)
• Knee height and arm spanA reflection of early life environment and risk of dementia

  T. L. Huang, M. C. Carlson, A. L. Fitzpatrick, L. H. Kuller, L. P. Fried, P. P. Zandi

  • Abstract
  • Full Text
  • Full Text (PDF)
• CSF biomarkers in frontotemporal lobar degeneration with known pathology

  H. Bian, J. C. Van Swieten, S. Leight, L. Massimo, E. Wood, M. Forman, P. Moore, I. de Koning, C. M. Clark, S. Rosso, J. Trojanowski, V. M.-Y. Lee, M. Grossman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Whole-brain atrophy rate in Alzheimer diseaseIdentifying fast progressors

  J. D. Sluimer, H. Vrenken, M. A. Blankenstein, N. C. Fox, P. Scheltens, F. Barkhof, W. M. van der Flier

  • Abstract
  • Full Text
  • Full Text (PDF)
• APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease

  S. Cosentino, N. Scarmeas, E. Helzner, M. M. Glymour, J. Brandt, M. Albert, D. Blacker, Y. Stern

  • Abstract
  • Full Text
  • Full Text (PDF)
• Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype

  K. A. Josephs, J. L. Whitwell, D. S. Knopman, W. T. Hu, D. A. Stroh, M. Baker, R. Rademakers, B. F. Boeve, J. E. Parisi, G. E. Smith, R. J. Ivnik, R. C. Petersen, C. R. Jack, D. W. Dickson

  • Abstract
  • Full Text
  • Full Text (PDF)
• Candesartan and cognitive decline in older patients with hypertensionA substudy of the SCOPE trial

  B. K. Saxby, F. Harrington, K. A. Wesnes, I. G. McKeith, G. A. Ford

  • Abstract
  • Full Text
  • Full Text (PDF)